72479-06-2 Usage
Description
(S)-5-OXO-2-PYRROLIDINEACETONITRILE, with the molecular formula C6H8N2O, is a nitrile derivative featuring a pyrrolidine ring and a ketone functional group. This chemical compound is widely recognized for its utility as a building block in organic synthesis and pharmaceutical research. Its potential as a chiral auxiliary in asymmetric synthesis further enhances its value, making it a significant player in the realm of medicinal chemistry and drug discovery.
Uses
Used in Pharmaceutical Research:
(S)-5-OXO-2-PYRROLIDINEACETONITRILE is used as a key component in the development of various pharmaceutical drugs and active ingredients. Its unique chemical structure and reactivity contribute to its importance in this field.
Used in Organic Synthesis:
In the realm of organic synthesis, (S)-5-OXO-2-PYRROLIDINEACETONITRILE serves as a vital building block, facilitating the creation of a diverse array of chemical compounds.
Used as a Chiral Auxiliary in Asymmetric Synthesis:
(S)-5-OXO-2-PYRROLIDINEACETONITRILE is also utilized as a chiral auxiliary, playing a crucial role in asymmetric synthesis. This application underscores its versatility and the breadth of its potential uses in chemical and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 72479-06-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,4,7 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 72479-06:
(7*7)+(6*2)+(5*4)+(4*7)+(3*9)+(2*0)+(1*6)=142
142 % 10 = 2
So 72479-06-2 is a valid CAS Registry Number.
72479-06-2Relevant articles and documents
On the absolute configuration of gephyrotoxin
Fujimoto,Kishi
, p. 4197 - 4198 (1981)
-
Synthesis of optically active (R)- And (S)-β-arginine from pyroglutamic acid
Yasuno, Yoko,Sawai, Akira,Sekihara, Ai,Shinada, Tetsuro
, p. 165 - 176 (2020/02/04)
– The first synthesis of optically active β-arginine was achieved starting from commercially available pyroglutamic acid. The new synthetic protocol is characterized by the use of nitrile as a carboxylic acid surrogate which could be transformed to the co
5-HT7 Receptor Antagonists with an Unprecedented Selectivity Profile
Ates, Ali,Burssens, Pierre,Lorthioir, Olivier,Lo Brutto, Patrick,Dehon, Gwenael,Keyaerts, Jean,Coloretti, Francis,Lallemand, Bénédicte,Verbois, Valérie,Gillard, Michel,Vermeiren, Céline
, p. 795 - 802 (2018/04/02)
-